Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.

Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.

Item
http://www.wikidata.org/entity/Q42803087
Up- and down-regulation of adiponectin expression and multimerization: mechanisms and therapeutic implicationCilostazol renoprotective effect: modulation of PPAR-γ, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusionBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialEffects of cilostazol on the progression and regression of symptomatic intracranial artery stenosis: it reduces the risk of ischemic strokeCilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis.Alterations in cyclic nucleotide phosphodiesterase activities in omental and subcutaneous adipose tissues in human obesity.Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without cardiovascular event.Phosphodiesterase-3 inhibition augments the myocardial infarct size-limiting effects of exenatide in mice with type 2 diabetes.Phosphodiesterase III inhibition increases cAMP levels and augments the infarct size limiting effect of a DPP-4 inhibitor in mice with type-2 diabetes mellitus.Haematoma scavenging in intracerebral haemorrhage: from mechanisms to the clinic.Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier.PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins.
P2860

Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.

Item
http://www.wikidata.org/entity/Q42803087
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Cilostazol ameliorates metabol ...... receptor gamma transcription.
@en
Cilostazol ameliorates metabol ...... receptor gamma transcription.
@nl
type
label
Cilostazol ameliorates metabol ...... receptor gamma transcription.
@en
Cilostazol ameliorates metabol ...... receptor gamma transcription.
@nl
prefLabel
Cilostazol ameliorates metabol ...... receptor gamma transcription.
@en
Cilostazol ameliorates metabol ...... receptor gamma transcription.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Cilostazol ameliorates metabol ...... receptor gamma transcription.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921